AXTINews Brief
UPDATE April 25: AXT exercised the over-allotment option on its public offering, adding 1.28mn shares and raising roughly $82.5mn in additional capital. The total offering now exceeds $630mn — materially larger than the $550mn we originally reported. The exercise signals stronger institutional demand than the initial pricing suggested; underwriters don't tap the greenshoe unless books are well-covered. That's the bullish read. The bearish read is straightforward: dilution just got worse. Every per-share metric in our original analysis — earnings, book value, cash per share — needs to be recalculated against a larger share count. Investors who sized positions based on the $550mn raise are now looking at ~15% more capital raised and correspondingly more shares outstanding. Watch for two things: first, how AXT deploys the incremental $82.5mn — whether it accelerates the capital plan or simply strengthens the balance sheet. Second, track post-offering trading volume and price action for signs the market has fully absorbed the larger float.

AXT Inc. Raises $550 Million After Earnings Hit — Stock Still Up 12%

AXT Inc. (AXTI) beat Q4 estimates, hit an all-time high, then sold $550mn worth of stock into the rally the same week.

AXT, Inc. (AXTI) — stock analysis
The numbers
  • AXTI surged 12% on Q4 earnings to an all-time high. The offering dragged shares back 5.2%.
  • The $550mn raise dwarfs $88mn in TTM revenue. The stock trades at 163.2x forward earnings.
  • B. Riley tripled its price target from $21 to $72 but held its rating at Neutral.

What Actually Happened

AXT makes compound semiconductor substrates — the specialized wafers used in data center lasers, power electronics, and other components tied to the AI infrastructure buildout. Q4 came in above expectations. The stock ripped 12% to a record.

Then management filed a $550mn common stock offering and closed it almost immediately. Companies don't do that when they think shares are cheap. They do it when the window is open and they want cash before it shuts. The offering closed fast, which signals institutional demand was there — but at a discount to the highs.

The B. Riley call deserves a closer look. The firm tripled its price target from $21 to $72, which sounds wildly bullish until you see the Neutral rating. Translation: the stock already reflects the thesis. The analyst is saying "I see why it's here," not "you should buy it here."

The Catch

The $550mn offering is more than 6x AXT's trailing twelve-month revenue. That is an enormous amount of dilution for a company this size. At 163.2x forward P/E, the stock prices in a revenue trajectory that needs to roughly double or triple from today's $88mn run rate just to bring the multiple down to something reasonable.

Compound semiconductor demand tied to AI is real. But AXT is a substrate supplier, not a chip designer. Substrate makers sit further from the end customer. That means less pricing power and more exposure to inventory cycles. If hyperscaler capex slows even modestly, AXT feels it before Nvidia does.

Bottom Line

Management just showed you what they think of the valuation. When a company raises 6x its annual revenue in a single offering days after an all-time high, that is the clearest signal a CEO can send without saying it out loud. The AI substrate story is real. But at 163x forward earnings, buyers are paying for several years of flawless results upfront.

Watch what they do with the $550mn. If next quarter's guidance shows revenue acceleration that justifies deploying that capital, the stock works. If the cash just sits on the balance sheet, you bought the top.

Want a full breakdown of AXT's financials and valuation? Generate a free Basis Report on AXTI.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Sources & filings